Medline Quarterly Cash Flow Statement
NASDAQ: MDLNHealth CareMedical/Dental InstrumentsUSD
36.26+0.52 (+1.45%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Medline free cash flow
In the quarter ended Jun 27, 2026, Medline generated $715.0 million of operating cash flow and spent $111.0 million on capital expenditures. That left free cash flow of $604.0 million, a free-cash-flow margin of 7.9% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Medline cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-27 | Q1 20262026-03-28 | Q2 20252025-06-28 | Q1 20252025-03-29 |
|---|---|---|---|---|
| Net Income | 139.00M | 239.00M | 329.00M | 319.00M |
| Net Income growth (YoY) | — | — | — | — |
| Depreciation & Amortization | 256.00M | 254.00M | 250.00M | 247.00M |
| Stock-Based Compensation | 29.00M | 23.00M | 15.00M | 19.00M |
| Change in Working Capital | -282.00M | -233.00M | -299.00M | -29.00M |
| Operating Cash Flow | 715.00M | 412.00M | 197.00M | 682.00M |
| Capital Expenditures | -111.00M | -96.00M | -110.00M | -98.00M |
| Investing Cash Flow | -461.00M | -96.00M | -143.00M | -92.00M |
| Share Repurchases | 0 | 0 | -6.00M | -9.00M |
| Financing Cash Flow | -159.00M | -13.00M | -328.00M | -9.00M |
| Net Change in Cash | 91.00M | 296.00M | -256.00M | 590.00M |
| Free Cash Flow | 604.00M | 316.00M | 87.00M | 584.00M |
This table shows 4 quarterly periods of Medline's cash flow statement, from Q2 2026 back to Q1 2025, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow MDLN's reporting calendar. What is a cash flow statement?